Last updated on April 2020

Prospective Record Of the Use of Dabigatran in Patients With Acute Stroke or TIA


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Brain Ischemia With Non-valvular Atrial Fibrillation | Transient Ischemic Attack With Non-valvular Atrial Fibrillation
  • Age: Between 18 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Age 18 years at enrollment
  • Male or female patient willing and able to provide written informed consent for data transmission. For patients who are not legally competent to sign this informed consent for data transmission exceptions/special cases are described in the protocol.
  • Patient with ischemic stroke or TIA within the last 7 days.
  • Patient diagnosed with non-valvular AF. Documentation of AF by 12 lead ECG, ECG rhythm strip, monitor print-out, pacemaker/ICD electrocardiogram, Holter ECG (duration of AF episode at least 30 seconds) or written physicians diagnosis prior to index event needed for all enrolled patients.

Exclusion Criteria:

  • Presence of any mechanical heart valve, or valve disease that is expected to require valve replacement intervention (surgical or non-surgical) during the next 3 months.
  • Current participation in any randomized clinical trial of an experimental drug or device.
  • Women of childbearing age without anamnestic exclusion of pregnancy or not using an effective contraception or nursing mothers.

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.